FDA
-
-
-
-
-
-
-
Pulmonx closes $60 million credit facility with Perceptive Advisors
-
-
-
-
-
-
-
Pulmonx reappoints Glen French as CEO, reports Q3 revenue of $21.5 million
-
-
-
-
-
-
-
Pulmonx to Report Second Quarter 2025 Financial Results on July 30, 2025
-
-
-
-
-
-
-
Pulmonx to Present at the Citi 2025 Unplugged Medtech and Life Sciences Access Day
-
-
-
-
-
-
-
Pulmonx Reports Third Quarter 2024 Financial Results
-
-
-
-
-
-
-
Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024
-
-
-
-
-
-
-
Pulmonx Announces Treatment of the First Patient with the AeriSealĀ® System in CONVERT II Pivotal Trial
-
325,893 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

